Results 101 to 110 of about 108,720 (196)

Diatomic iron nanozyme with lipoxidase-like activity for efficient inactivation of enveloped virus. [PDF]

Nat Commun, 2023
Li B, Ma R, Chen L, Zhou C, Zhang YX, Wang X, Huang H, Hu Q, Zheng X, Yang J, Yang J, Shao M, Hao P, Wu Y, Che Y, Li C, Qin T, Gao L, Niu Z, Li Y.   +19 more
europepmc   +1 more source

Differing Susceptibilities to Certain Microbicidal Chemistries among Three Representative Enveloped Viruses

Microorganisms
Three lipid-enveloped viruses (bovine viral diarrhea virus [BVDV], vaccinia virus, and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) were evaluated in side-by-side liquid inactivation efficacy studies of low pH (3.0 to 3.1) treatment and ...
Tanya Kapes, Charles Quinn, Andrew Eli Cragun, Taylor House, Raymond W. Nims, S. Steve Zhou   +5 more
doaj   +1 more source

Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses

Heliyon
The anti-viral properties of a small (≈1 kDa), novel Ru(II) photo dynamic compound (PDC), referred to as TLD-1433 (Ruvidar™), are presented. TLD-1433 had previously been demonstrated to exert strong anti-bacterial and anti-cancer properties. We evaluated
Kevin M. Coombs, Kathleen K.M. Glover, Raquel Russell, Pavel Kaspler, Mark Roufaiel, Drayson Graves, Peter Pelka, Darwyn Kobasa, Roger DuMoulin-White, Arkady Mandel   +9 more
doaj   +1 more source

Size-selective downstream processing of virus particles and non-enveloped virus-like particles. [PDF]

Front Bioeng Biotechnol, 2023
Hillebrandt N, Hubbuch J.
europepmc   +1 more source

Investigating Virus Clearance via pH Inactivation During Biomanufacturing [PDF]

, 2019
In the processing of biopharmaceuticals, viral clearance and viral safety are important for the development of monoclonal antibodies. Murine xenotropic leukemia virus (XMuLV) is one of the retroviruses, recommended by Food and Drug Administration (FDA ...
Xu, Wenbo
core   +2 more sources

The atlastin ER morphogenic proteins promote formation of a membrane penetration site during non-enveloped virus entry. [PDF]

J Virol, 2023
Pletan M, Liu X, Cha G, Chen YJ, Knupp J, Tsai B.   +5 more
europepmc   +1 more source

Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles. [PDF]

Microbiol Spectr, 2023
Choi W, Kim YH, Min J.
europepmc   +1 more source

Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. [PDF]

Cell Rep Med, 2023
Narayan R, Sharma M, Yadav R, Biji A, Khatun O, Kaur S, Kanojia A, Joy CM, Rajmani R, Sharma PR, Jeyasankar S, Rani P, Shandil RK, Narayanan S, Rao DC, Satchidanandam V, Das S, Agarwal R, Tripathi S.   +18 more
europepmc   +1 more source

Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses

Vaccines
Replication-competent virus particles hold significant therapeutic potential in application as oncolytic viruses or cancer vaccines. Ensuring the viral integrity of these particles is crucial for their infectivity, safety, and efficacy.
Adrian Schimek, Judy King Man Ng, Jürgen Hubbuch   +2 more
doaj   +1 more source

Non-enveloped virus membrane penetration: New advances leading to new insights. [PDF]

PLoS Pathog, 2022
Pletan ML, Tsai B.
europepmc   +1 more source